Published On:July 3, 2017, 4:05 pm
Bioresorbable Medical Materials are the biodegradable inside the human body. These materials are used to produce the temporary implants. These implants are used to support or enhance the any existing biological structure. Conventionally, such implants are manufactured from metal mesh and stay in the body for prolonged period until eliminated through further surgical treatment. But nowadays, these implants are fabricated from Bioresorbable materials, they serves the same purpose as traditional implants with the advantage that dissolve or be absorbed in the body so there is no need to operate it further. These materials are not harmful to body by any mean.
For example, if an implant manufactured using poly(L-lactide) is used in surgery for any part of human body, over the period poly(L-lactide) breaks down into lactic acid, a naturally occurring molecule that the body can use for metabolism. Generally, these materials begin to dissolve from six to twelve months and are completely dissolved between two and three years after it is placed in the body.
In 2016, the Bioresorbable medical material market was evaluated nearly USD 661.9 million. It is expected to reach whopping USD 1.5 billion by 2022. The compound annual growth rate is estimated to be tremendous 13.5% over the forecast period of 2017 to 2022. The major driving factor for the global bioresorbable medical market is the growth in patient’s comfort brought by bioresorbable materials. Conventional materials left in the body post-surgery required compulsory another minor surgery to remove those materials, some exhibiting a health risks to the patient.
Bioresorbable polymers rule out both these factors due to their property of degrade completely and are eliminated from the human body leaving no trace behind. The increasing demand for drugs, medicine and treatments as well as rising number of surgeries around the world is boosting the demand for bioresorbable medical materials. There is a huge investment in the product innovation by the companies in medical and healthcare industry, due to its increasing demand in the medical sector. The only restraining factor is their higher cost than the conventional materials. Also in some of remote n under developed areas in Latin America and Africa where, advanced healthcare is not available is hindering the market growth.
The key market players for the Bioresorbable medical material market are Sunwin Chemicals, Corbion N.V., American Crystal Sugar Company, Evonik Industries AG, Stepan Company, Foster Corporation, Poly-Med Inc., KLS Martin Group, Johnson & Johnson and KAO Corporation. By types the market is classified into; Polysaccharides, Polylactic Acid (PLA), Polycaprolactone (PCL), Polyglycolic Acid (PGA) and Proteins. According to applications the market is split into; Drug Delivery, Orthopedics and Others. Geographically, the global market is segmented into regions which are; Middle East AfricaNorth America, Latin America, Western Europe, Eastern Europe and Asia pacific.
Get Sample Copy Of Report@ https://www.qyresearchgroups.com/request-sample/423415
We will be happy to help you find what you need. Please write to us: